A Nevada based biotech firm recently added a new top of the line pain relief ointment to its line of products. Known as the Cannavera Pain Relief Ointment, this is the latest offering in the company’s line of cannabis-based oils, sprays and creams.
Leading Edge Pharms specializes in creating products with innovative delivery systems and unique cannabinoid therapies meant to help users get the relief they need almost instantly.
This latest product contains a nano-encapsulated compound called Silvidiol Liposome. This is a truly outstanding compound –currently awaiting patent approval- made up of emerald aloe vera and liposomal hemp, and created to help provide relief to patients suffering from nerve, joint, and muscular pains, as well as skin irritations triggered by inflammation.
In the company’s announcement of the product, David Chadwick, CEO of Leading Edge Pharms said the new product is a proven product, that doesn’t contain THC, and designed to maximally treat and provide pain relief. It does this by being rapidly absorbed in the skin, with the compound getting delivered straight to the pain receptors. According to him,
“Our new topical pain relief ointment provides another application option for our proven THC-free pain management treatments. While many CBD-based ointments are reaching the market, our Silvidiol Liposome, which forms the basis of our Cannavera products, has been proven as an effective delivery method able to permeate the skin to reach pain receptors and alleviate aches caused by injury or inflammation,” […] “We continue to pursue our goal of providing natural, safe and effective cannabinoid therapies through innovative delivery systems, answering a real market need for opioid-alternatives for pain relief.”
The new Cannavera Pain Relief Ointment is also accompanied by the company’s release of new smaller sized containers for its more popular sprays and cream. Users can now get them in small 30ml/1oz containers. These are great for carrying around, and applying on the go when you need frequent applications.